Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

ABSTRACT:

Aims

This study aimed to identify relationships in recently diagnosed atrial fibrillation (AF) patients with respect to anticoagulation status, use of guideline-directed medical therapy (GDMT) for comorbid cardiovascular conditions (co-GDMT), and clinical outcomes. The Global Anticoagulant Registry in the FIELD (GARFIELD)-AF is a prospective, international registry of patients with recently diagnosed non-valvular AF at risk of stroke (NCT01090362).

Methods and results

Guideline-directed medical therapy was defined according to the European Society of Cardiology guidelines. This study explored co-GDMT use in patients enrolled in GARFIELD-AF (March 2013-August 2016) with CHA₂DS₂-VASc ≥ 2 (excluding sex) and ≥1 of five comorbidities-coronary artery disease

SUBMITTER: Camm AJ 

PROVIDER: S-EPMC10246824 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature